US83422E2046
US83422E2046
Solid Biosciences Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 179.206.000 | 129.728.000 | 38.1% | |
| Operating Income | -179.206.000 | -129.728.000 | 38.1% |
| Pretax Income | -174.325.000 | -124.697.000 | 39.8% |
| Net Income Common Stockholders | -174.325.000 | -124.697.000 | 39.8% |
| -- | -- | -- | |
| -- | -- | -- |